About GRAIL
                            Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.                        
                                                    
                                    Headquarters
                                    GRAIL, Menlo Park
                                
                                                                                                
                                    Founded
                                    2016-01-01
                                
                                                                
                                                                
                                    Industry
                                    Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
                                
                                                                                                
                                    Last Funding Type
                                    Series D
                                
                                                                                                    
                                        Valuation
                                        1.1
                                    
                                                                                                
                                                                        Total Funding
                                    $2.00 billion dollars
                                
                                                                                                
                                    IPO Status
                                    Public
                                
                                                            Financial
                                    Funding Rounds
                                    5
                                
                                                                                                
                                    Number of Lead Investors
                                    6
                                
                                                                                                
                                                                        Total Funding Amount 
                                    $2.00 billion dollars
                                
                                                                                                
                                    Number of Investors
                                    24